Interestingly, as mentioned above, an increased level of nuclear β-catenin in ovarian cancer is correlated with a favorable patient prognosis, so the growth-suppressing function of WNT5a in this tumor type may not stem from the inhibition of CTNNB1 signaling, but from the regulation via non-canonical WNT signaling. Here, CTNNB1 is linked to neoplasm.